These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17050866)

  • 1. Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study.
    Papotti M; Kalebic T; Volante M; Chiusa L; Bacillo E; Cappia S; Lausi P; Novello S; Borasio P; Scagliotti GV
    J Clin Oncol; 2006 Oct; 24(30):4818-24. PubMed ID: 17050866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
    Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
    J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of serum bone sialoprotein in patients with bone metastasis of non-small cell lung cancer.
    He JJ; Zhi K; Liu GF
    Onkologie; 2011; 34(11):584-8. PubMed ID: 22104154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.
    Lu C; Soria JC; Tang X; Xu XC; Wang L; Mao L; Lotan R; Kemp B; Bekele BN; Feng L; Hong WK; Khuri FR
    J Clin Oncol; 2004 Nov; 22(22):4575-83. PubMed ID: 15542809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.
    Diel IJ; Solomayer EF; Seibel MJ; Pfeilschifter J; Maisenbacher H; Gollan C; Pecherstorfer M; Conradi R; Kehr G; Boehm E; Armbruster FP; Bastert G
    Clin Cancer Res; 1999 Dec; 5(12):3914-9. PubMed ID: 10632320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
    Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
    Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
    Milas I; Komaki R; Hachiya T; Bubb RS; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
    Clin Cancer Res; 2003 Mar; 9(3):1070-6. PubMed ID: 12631609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers.
    Waltregny D; Bellahcène A; de Leval X; Florkin B; Weidle U; Castronovo V
    J Bone Miner Res; 2000 May; 15(5):834-43. PubMed ID: 10804012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment.
    Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of collagen XVIII and its prognostic value in nonsmall cell lung carcinoma.
    Chang H; Iizasa T; Shibuya K; Iyoda A; Suzuki M; Moriya Y; Liu TL; Hiwasa T; Hiroshima K; Fujisawa T
    Cancer; 2004 Apr; 100(8):1665-72. PubMed ID: 15073855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.
    Kawai H; Ishii A; Washiya K; Konno T; Kon H; Yamaya C; Ono I; Minamiya Y; Ogawa J
    Clin Cancer Res; 2005 Jul; 11(14):5084-9. PubMed ID: 16033821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of heparanase activity in primary resected non-small cell lung cancer.
    Takahashi H; Ebihara S; Okazaki T; Suzuki S; Asada M; Kubo H; Sasaki H
    Lung Cancer; 2004 Aug; 45(2):207-14. PubMed ID: 15246192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for patients with spinal metastases from lung cancer.
    Ogihara S; Seichi A; Hozumi T; Oka H; Ieki R; Nakamura K; Kondoh T
    Spine (Phila Pa 1976); 2006 Jun; 31(14):1585-90. PubMed ID: 16778693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.
    Zhang L; Hou X; Lu S; Rao H; Hou J; Luo R; Huang H; Zhao H; Jian H; Chen Z; Liao M; Wang X
    Lung Cancer; 2010 Jan; 67(1):114-9. PubMed ID: 19376608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of different markers in non-small cell lung cancer: prognostic value of clinical staging, tumour cell detection and tumour marker analysis for tumour progression and overall survival.
    Kasimir-Bauer S; Schleucher N; Weber R; Neumann R; Seeber S
    Oncol Rep; 2003; 10(2):475-82. PubMed ID: 12579292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.